2023
|
Invention
|
Methods and systems for characterization, diagnosis, and treatment of cancer. Disclosed herein ar... |
|
Invention
|
Quinazoline derivatives as inhibitors of the gcn2 kinase, compositions and uses thereof. The pres... |
|
Invention
|
Isoquinoline derivatives as inhibitors of bax and/or bak, compositions and uses thereof. The pres... |
2022
|
Invention
|
Mitochondrial dna prostate cancer marker and related systems and methods.
There is described her... |
|
Invention
|
Halo-substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor ki... |
|
Invention
|
Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1... |
|
Invention
|
Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase ... |
|
Invention
|
Compounds, compositions and methods of treating cancer. The present application relates to halo-s... |
|
Invention
|
Substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk... |
|
Invention
|
Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses ther... |
|
Invention
|
Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and ... |
2021
|
Invention
|
Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof.
The presen... |
|
Invention
|
Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof. The present... |
|
Invention
|
Molecular classifiers for prostate cancer.
There is described herein a method of predicting dise... |
|
Invention
|
Molecular classifiers for prostate cancer. There is described herein a method of predicting disea... |
2020
|
Invention
|
Unsaturated heterocycloalkyl and heteroaromatic acyl hydrazone linkers, methods and uses thereof.... |
|
Invention
|
Pan-cancer transcriptional signature.
There is described herein a pan-cancer transcriptional sig... |
|
Invention
|
Pan-cancer transcriptional signature. There is described herein a pan-cancer transcriptional sign... |
|
Invention
|
Amide-based proteolysis modulators of b-rapidly accelerated fibrosarcoma (braf) and associated us... |
2019
|
Invention
|
Compounds and methods for treating nematode infections. The present application relates to the tr... |
|
Invention
|
Substituted heteroaryls as inhibitors of the bcl6 btb domain protein-protein interaction. The pre... |
|
Invention
|
Inhibitors of the bcl6 btb domain protein-protein interaction and uses thereof. The present appli... |
2018
|
Invention
|
Tricyclic inhibitors of the bcl6 btb domain protein-protein interaction and uses thereof. The pre... |
|
Invention
|
Deuterated compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/or as b... |
|
Invention
|
Novel deuterated compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/o... |
|
Invention
|
Heterocyclic acyl hydrazone linkers, methods and uses thereof. The present application is directe... |
|
Invention
|
Quinolone compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/or as bc... |
|
Invention
|
Quinolone compounds as inhibitors of the bcl6 btb domain protein-p rotein interaction and/or as b... |
|
Invention
|
Acyl hydrazone linkers, methods and uses thereof. The present application is directed to compound... |